Ikena Oncology, Inc. - Common Stock (NQ:IKNA)

1.430 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ikena Oncology, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Ikena Oncology Receives FDA Fast Track Designation for Novel AHR Antagonist IK-175 in Combination with Nivolumab to Treat Urothelial Carcinoma

March 06, 2023

From Ikena Oncology, Inc.

Via GlobeNewswire

Ikena Oncology to Participate in Cowen 43rd Annual Health Care Conference

February 28, 2023

From Ikena Oncology, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 14, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

December 27, 2022

Via Benzinga

Ikena Oncology's Return On Capital Employed Insights ↗

November 30, 2022

Via Benzinga

Ikena Oncology: Q3 Earnings Insights ↗

November 07, 2022

Ikena Oncology (NASDAQ:IKNA) reported its Q3 earnings results on Monday, November 7, 2022 at 08:05 AM. Here's what investors need to know about the announcement.

Via Benzinga

Ikena Oncology: Q2 Earnings Insights ↗

August 11, 2022

Ikena Oncology (NASDAQ:IKNA) reported its Q2 earnings results on Thursday, August 11, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Ikena Oncology Appoints Owen Hughes as Board Chair

December 19, 2022

From Ikena Oncology, Inc.

Via GlobeNewswire

Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session ↗

December 09, 2022

Gainers Ambrx Biopharma Inc. (NYSE: AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate.

Via Benzinga

Ikena Oncology Announces New Cancer Program, Shelves Early Asset For Colorectal Cancer ↗

November 28, 2022

Ikena Oncology Inc (NASDAQ: IKNA) nominated a next-generation mitogen-activated protein kinase (MEK)-RAF complex inhibitor, IK-595, as its first development candidate in the RAS pathway.

Via Benzinga

Ikena Oncology Announces New Program in Next-Generation MEK-RAF Inhibition and Provides Corporate Update

November 28, 2022

From Ikena Oncology, Inc.

Via GlobeNewswire

Ikena Oncology to Participate in the Piper Sandler 34th Annual Healthcare Conference

November 22, 2022

From Ikena Oncology, Inc.

Via GlobeNewswire

Ikena Oncology Announces Initial Clinical Data from IK-175 Program in Urothelial Carcinoma

November 10, 2022

From Ikena Oncology, Inc.

Via GlobeNewswire

UPDATE -- Ikena Oncology Reports Third Quarter 2022 Financial Results and Provides a Corporate Update

November 07, 2022

From Ikena Oncology, Inc.

Via GlobeNewswire

Ikena Oncology Reports Third Quarter 2022 Financial Results and Provides a Corporate Update

November 07, 2022

From Ikena Oncology, Inc.

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Monday ↗

October 31, 2022

During Monday's session, 96 stocks hit new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 26, 2022

Gainers

Via Benzinga

Ikena Oncology Presents Preclinical Data at the 34th EORTC-NCI-AACR Symposium on Novel TEAD Inhibitor, IK-930, Combating Therapeutic Resistance

October 26, 2022

From Ikena Oncology, Inc.

Via GlobeNewswire

Ikena Oncology Provides Research & Development Update on IK-930 Program Targeting the Hippo Pathway

October 18, 2022

From Ikena Oncology, Inc.

Via GlobeNewswire

Ikena Oncology to Present Initial Phase 1a/b Results from Novel AHR Inhibition Program at the 2022 Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting

October 05, 2022

From Ikena Oncology, Inc.

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Tuesday ↗

October 25, 2022

On Tuesday, 120 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 31, 2022

Gainers

Via Benzinga

Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday ↗

June 27, 2022

Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Schenker and USA Truck announced plans to combine and create premier North American transportation...

Via Benzinga

The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral ↗

June 22, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Ikena Oncology Secures Fast Track designation From FDA For Pleural Cancer Candidate ↗

June 22, 2022

Ikena Oncology, Inc. (NASDAQ: IKNA) received Fast Track designation from the U.S. Food and Drug Administration (FDA) for IK-930, in patients with unresectable NF2-deficient malignant pleural...

Via Benzinga

5 Value Stocks To Watch In The Healthcare Sector ↗

June 06, 2022

The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 01, 2022

Via Benzinga

77 Biggest Movers From Yesterday ↗

June 01, 2022

Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) shares climbed 364% to close at $9.93 on Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 05, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

May 02, 2022

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.